Mental health improvements of substance-dependent clients after 4 months in a Therapeutic Community

Drug and Alcohol Review

Volumn 29, Issue 5, 2010, Pages 546-550

  Polimeni, Anne Maree ^a   Moore, Susan M ^b   Gruenert, Stefan ^a  

^a Odyssey Institute   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Dual diagnosis; Mental health; MMPI 2; Substance dependency; Therapeutic Community

Indexed keywords

ADDICTION; ADULT; ARTICLE; AUSTRALIA; DRUG DEPENDENCE TREATMENT; FEMALE; HUMAN; MALE; MENTAL DISEASE; MIDDLE AGED; PHILOSOPHY; PSYCHIATRIC DIAGNOSIS; PSYCHOMETRY; THERAPEUTIC COMMUNITY; TIME; TREATMENT OUTCOME;

ADULT; AUSTRALIA; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HOLISTIC HEALTH; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PSYCHOMETRICS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; THERAPEUTIC COMMUNITY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957892595     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2010.00175.x     Document Type: Article

References (26)

1. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B. The Minnesota Multiphasic Personality Inventory-2 (MMPI-2): manual for administration and scoring. Minneapolis, MN: University of Minnesota Press, 1989.
2. Drake RE, Mueser KT, Brunette MF. Management of persons with co-occurring severe mental illness and substance use disorder: program implications. World Psychiatry 2007;6:131-6.
3. Mueser KT, Yarnold PR, Levinson DF, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990;16:31-56.
4. Goodwin FK, Jamison KR. Manic depressive illness. New York: Oxford University Press, 1990.
5. Safer D. Substance abuse by young adult chronic patients. Hosp Community Psychiatry 1987;38:511-14.
6. Reiger DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area study. J Am Med Assoc 1990;264:2511-18.
7. Bartels SJ, Teague GB, Drake RE, Clark RE, Bush P, Noordsy DL. Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Disord 1993;181:227-32.
8. Clark RE. Family costs associated with severe mental illness and substance use: a comparison of families with and without dual disorders. Hosp Community Psychiatry 1994;45:808-13.
9. Cournos F, Empfield M, Horwath E, et al. HIV seroprevalence among patients admitted to two psychiatric hospitals. Am J Psychiatry 1991;148:1225-30.
10. DeLeon G. Psychopathology and substance abuse. What is being learned from research in therapeutic communities. J Psychoactive Drugs 1989;21:177-88.
11. DeLeon G. Therapeutic communities for addictions: a theoretical framework. Int J Addict 1995;30:1603-45.
12. Melnick G, DeLeon G. Clarifying the nature of therapeutic community treatment. J Subst Abuse Treat 1999;16:307-13.
13. Rutter D, Crawford M. The efficacy of therapeutic communities in the treatment of personality disorders. Psychiatry 2005;4:19-22.
14. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1-year follow-up outcomes in the drug abuse treatment outcome study. Psychol Addict Behav 1997;11:261-78.
15. Simpson DD, Sells S. Effectiveness of treatment for drug abuse. An overview of the DARP program. Adv Alcohol Subst Abuse 1982;2:7-29.
16. de Groot MH, Franken IHA, van der Meer CW, Hendriks VM. Stability and change in dimensional ratings of personality disorders in drug abuse patients during treatment. J Subst Abuse 2003;24:115-20.
17. DeLeon G, Jainchill N. Male and female drug abusers: social and psychological status 2 years after treatment in a therapeutic community. Am J Drug Alcohol Abuse 1981-1982;8:465-97.
18. Schinka JA, Hughes PH, Coletti SD, et al. Changes in personality characteristics in women treated in a therapeutic community. J Subst Abuse Treat 1999;16:137-42.
19. Groth-Marnat G. Handbook of psychological assessment, 3rd edn. New York: John Wiley, 1997.
20. DeLeon G, Sacks S, Staines G, McKendrick K. Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes. Am J Drug Alcohol 2000;26:461-79.
21. Rahav M, Rivera JJ, Nuttbrock L, et al. Characteristics and treatment of homeless, mentally ill, chemical-abusing men. J Psychoactive Drugs 1995;27:93-103.
22. Westreich L, Galanter M, Lifshutz H, Metzger EJ, Silberstein C. A modified therapeutic community for the dually diagnosed. J Subst Abuse Treat 1996;6:533-6.
23. DeLeon G, Jainchill N. Residential therapeutic communities for female substance abusers. Bull N Y Acad Med 1991;67:277-90.
24. Polimeni A-M, Moore SM, Gruenert S. MMPI-2 profiles of clients with substance dependencies accessing a therapeutic community treatment facility. e-J Appl Psychol 2010. In press.
25. Forbey JD, Ben-Porath YS. A comparison of the MMPI-2 restructured clinical (RC) and clinical scales in a substance abuse treatment sample. Psychol Serv 2007; 4:46-58.
26. Gerra G, Bertacca S, Zaimovic A, Pirani M, Branchi B, Ferri M. Relationship of personality traits and drug of choice by cocaine addicts and heroin addicts. Subst Use Misuse 2008;43:317-30.